|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N2501/24 | (2013.01) | ||
| C12N2501/2315 | (2013.01) | ||
| C12N2501/2312 | (2013.01) | ||
| C12N2501/2318 | (2013.01) | ||
| C12N2501/2302 | (2013.01) | ||
| C12N 5/0646 | (2013.01) |
| (11) | Number of the document | 3548610 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17803974.9 |
| Date of filing the European patent application | 2017-11-29 | |
| (97) | Date of publication of the European application | 2019-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/080848 |
| Date | 2017-11-29 |
| (87) | Number | WO 2018/099988 |
| Date | 2018-06-07 |
| (30) | Number | Date | Country code |
| 201600121081 | 2016-11-29 | IT |
| (72) |
BADAMI, Ester , IT
|
| (73) |
Fondazione Ri.MED ,
Via Bandiera 11, 90133 Palermo,
IT
Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione . ISMETT , Via Discesa dei Giudici 4, 90133 Palermo (PA), IT |
| (54) | NK-MEDIATED IMMUNOTHERAPY AND USES THEREOF |
| NK-MEDIATED IMMUNOTHERAPY AND USES THEREOF |